Results 131 to 140 of about 1,991 (194)

ODYSSEY-HCM trial (mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy). [PDF]

Eur Heart J Cardiovasc Pharmacother
Monda E, Limongelli G.
europepmc   +1 more source

Mavacamten Monotherapy in Real-World Patients With Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCM. [PDF]

Circ Genom Precis Med
Bilen O, Adler A, Bastiaenen R, MacNamara JP, Paratz E, Maor E, Arad M, Gold M, Patel N, Pruett C, Burford E, Arora G, Maksabedian Hernandez EJ, Han X, Schuler P, Sandler B, Li L, Tian D, Arora P, COLLIGO-HCM investigators.   +19 more
europepmc   +1 more source

Use of Advanced Transthoracic Echocardiography in Special Cardiac Conditions [PDF]

Nagy Viktória
core  

Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

J Pers Med
Katic J, Bulum T, Borovac JA.
europepmc   +1 more source

Long-Term Real-World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks. [PDF]

J Clin Med
Reza N, Dubey A, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Marzolf A, Hornsby N, de Feria A, Carattini T, Schuler P, Owens AT.   +12 more
europepmc   +1 more source

Complete left bundle branch block resolution during treatment with Mavacamten: a case report of a first-in-class scenario. [PDF]

Eur Heart J Case Rep
Marchionni G, Alfarano M, Ballatore F, Costantino J, Chimenti C.   +4 more
europepmc   +1 more source

Mavacamten in hypertrophic obstructive cardiomyopathy with hepato-renal comorbidities: A case report. [PDF]

Medicine (Baltimore)
Ma L, Li F, Dong S, Li R.
europepmc   +1 more source

Response to the letter to the editor concerning: 'catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten: case report'. [PDF]

Eur Heart J Case Rep
De Roeck F, Gevaert AB, Van Craenenbroeck E.   +2 more
europepmc   +1 more source